An autonomous drug release system based on chemo-mechanical energy conversion "Organic Engine" for feedback control of blood glucose.
A novel autonomous drug release system was fabricated and tested. The system consists of two integrated units: decompression unit and drug release unit. The decompression unit was fabricated by separating a cylindrical cell into a top cell (gas phase) and a bottom cell (liquid phase) by glucose oxidase (GOD) enzyme immobilized membrane. The enzyme membrane recognizes glucose and converts chemical energy found in glucose to mechanical energy. The linear correlation between glucose concentration and de-pressure slope of the top cell was revealed as applying glucose solution to the bottom cell. Afterward, the drug release unit which utilizes the energy of the decompression unit as a power source was fabricated and evaluated by recording its release actions. The drug release unit was made to release at a constant quantity of drug in the liquid phase. The system was then fabricated by combining the decompression unit and the drug release unit. And it was evaluated in an open loop and in a closed loop by applying a mixture of glucose solution (100 mmol/l) and NADH(+) using glucose dehydrogenase enzyme (GDH) as a glucose reducer. Glucose concentration decreased gradually in the closed loop and, as a consequence, interval time of the GDH release became longer. In other words, an inverse correlation between actuation interval of the system and glucose concentration was shown. As a result, the possibility of feedback control of glucose concentration by the drug release system without external energy was confirmed.
Kato
Ryodai
R
Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8549, Japan.
Munkhjargal
Munkhbayar
M
Takahashi
Daishi
D
Arakawa
Takahiro
T
Kudo
Hiroyuki
H
Mitsubayashi
Kohji
K
D001674:Bioelectric Energy Sources; D015374:Biosensing Techniques / Q000295:instrumentation* / Q000379:methods*; D001786:Blood Glucose / Q000032:analysis*; D016503:Drug Delivery Systems / Q000295:instrumentation* / Q000379:methods*; D004800:Enzymes, Immobilized; D004867:Equipment Design; D025461:Feedback, Physiological; D005949:Glucose Oxidase; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000008:administration & dosage; D007332:Insulin Infusion Systems
D001786:Blood Glucose; D004800:Enzymes, Immobilized; D007328:Insulin; D005949:Glucose Oxidase